Publication Topic

Su J, Bylsma LC, Jiang X, Morales Arias J, Jain N, Nordyke RJ. Healthcare resource utilization among commercially insured cold agglutinin disease patients in the United States. Poster presentation at International Society for Pharmacoeconomics and Outcomes Research, New Orleans, Louisiana, May 18–22, 2019.

Cronin-Fenton D, Dalvi T, Fryzek J, Hansen H, Hamilton-Dutoit S, Hedgeman E, Mellemgaard A, Norgaard M, Pedersen L, Potter D, Rasmussen TR, Rigas J, Shire N, Sorensen HT, Walker J. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the International Society for Pharmacoepidemiology Annual Conference, August 22-26, 2018, Prague, Czech Republic.

Ruzin A, Pastula ST, Levin-Sparenberg E, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Qi Y, Liu H, Jin H, Yu L, Hackett J, Villafana T, Esser MT. 2018. Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS One 13(7):e0200319.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the American Association for Cancer Research (AACR) Annual Meeting 2018, April 14-18, 2018, Chicago, IL.

Bylsma LC, Gulbech Ording A, Froslev T, Mehnert F, Fryzek JP, Morales Arias J, Roth A, Sorensen HT, Berentsen S. Occurrence, survival, and thromboembolic risk in cold agglutinin disease: a population-based cohort analysis. Presented at the 23rd Congress of the European Hematology Association, June 14-17 2018, Stockholm, Sweden.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW. 2018. Patterns of bicalutamide use in prostate cancer treatment: A U.S. real-world analysis using the SEER-Medicare database. Adv Ther 35(1):1438-1451.

Schwartz KL, Simon MS, Bylsma LC, Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM,  Flanders SC, Barlev A, Fryzek JP, Quek RGW. 2018. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States. Cancer 124(10):2104-2114.

Bylsma LC, Gillezeau C, Garawin T, Kelsh M, Fryzek J, Sangare L, Lowe KA. Prevalence of RAS and BRAF Mutations in Metastatic Colorectal Cancer (mCRC) Patients by Tumor Location. Presented at the Gastrointestinal Cancers Symposium, January 18-20, 2018, San Francisco, CA.

Fryzek JP, Reichert H, Summers N, Townes L, Deuson R, Alexander DD, Vanderpuye-Orgle J. 2018. Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen. PLoS One 13(4):e0195790.

Mullins M, Jiang X, Bylsma LC, Fryzek JP, Reichert H, Chen EC, Kummar S, Rosenthal A. 2017. Cold agglutinin disease burden: A longitudinal analysis of anemia, medications, transfusions, and healthcare utilization. Blood Adv 1:839-848.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Lawrence D, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mutations in First-Line Therapy (1L) for non-small cell lung cancer (NSCLC) patients. Presented at the 18th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) 2017, October 15-18, 2017, Yokohama, Japan.

Bylsma LC, Gage SM, Reichert H, Dahl SLM, Lawson JH. 2017. Arteriovenous fistulas for hemodialysis: A systematic review and meta-analysis of efficacy and safety outcomes. Eur J Vasc Endovasc Surg 54:513e522.

Broome C, Cunningham JM, Mullins M, Jiang X, Bylsma L, Fryzek J, Rosenthal A. Incidence of Thromboembolic Events Is Increased in a Retrospective Analysis of a Large Cold Agglutinin Disease (CAD) Cohort. Presented at the American Society of Hematology, December 9-12, 2017, Atlanta, GA.

Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston SA, Okerson T. Monitoring Frequency After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association Scientific Sessions, November 11-15, 2017, Anaheim, CA.

Friedman D, Fryzek J, Jiang X, Bloomfield A, Ambrose CS, Wong PC. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS One. 2017 Mar 2;12(3):e0172512.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. 2017. Hospitalizations for Respiratory Syncytial Virus among adults in the United States, 1997 to 2012.  2017. Open Forum Infectious Diseases 4(1):ofw270.

Ruzin A, Levin-Sparenberg E, Pastula, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Yu L, Hackett J, Villafana T, Esser MT. Characterization of RSV Strains Among U.S. Patients in the OUTSMART RSV Program During 2015-16. Presented at ID Week 2017, October 4-6, 2017, San Diego, CA.

Okerson T, Cohen SS, Killian JM, Weston SA, Monda KL, Chamberlain AM. Changes in Lipid-Lowering Therapy Following a Cardiovascular Event in Patients with Diabetes Mellitus. Presented at the 53rd Annual Meeting of the European Assocation for the Study of Diabetes, September 11-15, 2017, Lisbon, Portugal.

Soff GA, Ray-Coquard I, Marfil Rivera LJ, Fryzek J, Mullins M, Bylsma LC, Park JK. Literature Review of Thrombopoietin Receptor Agonists (TPO-RA) for Chemotherapy-Induced Thrombocytopenia (CIT). Presented at the European Society for Medical Oncology 2017 Congress, September 8-12, 2017, Madrid, Spain.

Chamberlain AM, Cohen SS, Killian JM, Weston SA, Okerson T, Monda KL. Changes in Lipid-Lowering Therapy Prescription Patterns following a Second Cardiovascular Disease Event. Presented at the European Society of Cardiology Congress 2017, August 26-30, 2017, Barcelona, Spain.

Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston SA, Okerson T. Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Atherosclerotic Cardiovascular Disease. Presented at the American Diabetes Association’s 77th Scientific Sessions, June 9-13, 2017, San Diego, CA.

Ruterbusch JJ, Bylsma LC, Fryzek J, Barlev A, et al. Bicalutamide Treatment Patterns in Elderly Prostate Cancer Patients: A Historical Cohort Study Using the Surveillance, Epidemiology and End Results Program (SEER)-Medicare Database. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, May 20-24, 2017, Boston, MA.

Fryzek JP, Ruterbusch JJ, Garabrant DH, Dalvi T, Beebe-Dimmer JL. Healthcare Resource Utilization and Costs of Care for Mesothelioma Medicare Beneficiaries. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting, May 20-24, 2017, Boston, MA.

Chamberlain AM, Cohen SS, Killian JM, Monda KL, Hedgeman E, Weston SA, Okerson T. Lipid-lowering Therapy Prescription Patterns and Predictors of High Intensity Statin Prescriptions in Patients With Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association’s Epidemiology and Prevention – Lifestyle 2017 Scientific Sessions, March 7, 2017, Portland, OR.

Cukor D, Cohen LM, Cope EL, Ghahramani N, Hedayati SS, Hynes DM, Shah VO, Tentori F, Unruh M, Bobelu J, Cohen SS, Dember LM, Faber T, Fischer MJ, Gallardo R, Germain MJ, Ghahate D, Grote N, Hartwell L, Heagerty P, Kimmel PL, Kutner N, Lawson S, Marr L, Nelson RG, Porter AC, Sandy P, Struminger BB, Subramanian L, Weisbord S, Young B, Mehrotra R. 2016. Patient and other stakeholder engagement in patient-centered outcomes research institute funded studies of patients with kidney diseases. Clin J Am Soc Nephrol 11(9):1703-1712.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Mortensen K, Midta A, Shire N, Brody R, Fryzek J, Lawrence D, Rigas J, Potter D, Walker J, Mellemgaard A, Rasmussen TR, Hamilton-Dutoit S, Sorensen HT. An interim assessment of key biomarkers (programmed cell death receptor ligand 1 (PD-L1) expression and epidermal growth factor receptor (EGFR) in third-line therapy non-small cell lung cancer (NSCLC) patients: A Danish cohort study. Presented at the 41st European Society for Medical Oncology (ESMO) Congress, October 7-11 2016, Copenhagen, Denmark.

Chamberlain AM, Cohen SS, Killian JM, Beaubrun AC, Monda KL, Hedgeman E, Weston SA, Okerson T. Lipid-Lowering Therapy Prescriptions Immediately Before and After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association Scientific Sessions, November 1, 2016, New Orleans, LA.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of Respiratory Syncytial Virus Disease among Adults in the United States from 1997 to 2012. Presented at ID Week 2016, October 26-30, 2016, New Orleans, LA.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of respiratory syncytial virus disease among adults in the United States from 1997 to 2012. Presented at the International Society for Influenza and Other Respiratory Virus Diseases (ISIRV) 2016 – Options IX For the Control of Influenza, August 24-28, 2016, Chicago, IL.

Cetin K, Callaghan F, Fryzek J, Bylsma L, Bezold C, Mehta B. Safety and Efficacy/Effectiveness of 2nd-line Treatments in Immune Thrombocytopenia (ITP): A Systematic Review of the Literature. Presented at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 25-28, 2016, Dublin, Ireland.

Cetin K, Callaghan F, Fryzek J, Bylsma L, Bezold C, Mehta B. Safety and Efficacy/Effectiveness of Second-line Treatments in Patients with Immune Thrombocytopenia: A Systematic Review of the Literature. Presented at the 21st Congress of the European Hematology Association, June 9 – 12, 2016, Copenhagen, Denmark.

Fryzek J, Alexander DD, Summers N, Fraysse J, Reichert H, Townes L, Vanderpuye-Orgle J. Indirect treatment comparison of cabazitaxel for patients with metastatic castration-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen. Presented at the 21st Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 21-25, 2016, Washington, DC.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of Respiratory Syncytial Virus Disease Among Adults in the United States from 1997 to 2012. Presented at the 21st Annual International Society for Pharacoeconomics and Outcomes Research, May 21-25, 2016, Washington, DC.

Meddings J, Kuhn L, Reichert H. Indwelling Urinary Catheter Awareness, Order, and Indications in ICUs. Presented at the Society for Healthcare Epidemiology of America (SHEA) Annual Meeting, May 18-21, 2016, Atlanta, GA.

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the Society of General Internal Medicine (SGIM) 2016 Annual Meeting, May 11-14, 2016, Hollywood, FL.

Cetin K, Callaghan F, Fryzek JP, Bylsma LC, Bezold C, Mehta B. Safety and Efficacy/Effectiveness of Second-line Treatments in Patients with Immune Thrombocytopenia: A Systematic Review of the Literature. Presented at the Thrombosis & Hemostasis Summit of North America 2016, April 14-16, 2016, Chicago, IL.

Bylsma LC. Safety and Efficacy/Effectiveness of Second-line Treatments in Patients with Immune Thrombocytopenia: A Systematic Review of the Literature. Presented at the 3rd Biennial Summit of the Thrombosis & Hemostasis Societies of North America, April 14-16, 2016, Chicago, IL.

Cohen SS, Shirey-Rice J, Hardin J, Monda K, Fryzek JP, Fazio S, Denny JC, Wei WQ, Lipworth LL. Identification of patients with familial hypercholesterolemia (FH) using the Dutch Lipid Network (DLN) criteria in Electronic Health Records (EHR). Presented at the American Heart Association EPI Lifestyle Scientific Sessions, March 1-4, 2016, Phoenix, AZ.

Nguyen-Nielsen M, Wang L, Pedersen L, Braae Olesen A, Hou K, Mackey H, McCusker M, Basset-Seguin N, Fryzek JP, Vyberg M. 2015. The incidence of metastatic basal cell carcinoma in Denmark 1997-2010. Eur J Dermatol 25, DOI: 10.1684/ejd.2015.2546.

Cohen SS, Kabagambe EK, Shirey-Rice J, Hardin J, Monda K, Fryzek JP, Fazio S, Denny JC, Wei WQ, Lipworth LL. Achievement of LDL-cholesterol reduction targets is associated with reduced cardiovascular disease risk among patients with familial hypercholesterolemia in a large electronic medical record database. Presented at the American Heart Association 2015 Scientific Sessions, November 7-11, 2015, Orlando, FL.

Fryzek J, Doucette A, Jiang X, Coalson J, McLaurin K, Ambrose CS. Trends in Respiratory Syncytial Virus and Bronchiolitis Infant Hospitalization Rates in High-Risk Infants in a US Nationally Representative Database (1997–2012). Presented at ID Week, October 7-11 2015, San Diego, CA.

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the 2015 Agency for Heathcare Research and Quality (AHRQ) Research Conference, October 4-6, 2015, Crystal City, VA.

Lipworth LL, Shirey-Rice J, Wei WQ, Hardin J, Shi G, Monda K, Fryzek JP, Fazio S, Cohen SS, Denny JC. Identification and characterization of heterozygous familial hypercholesterolemia patients using the Vanderbilt University Medical Center Synthetic Derivative database. Presented at the European Society for Cardiology Congress, August 29 – September 1, 2015, London, United Kingdom.

Doucette A, Hedgeman E, Fryzek J. Assessing the Agreement of Hospitalization Estimates Between Three Nationally Representative US Hospital Discharge Databases, the Nationwide Inpatient Sample (NIS), the National Hospital Discharge Survey (NHDS) and the Kid’s Inpatient Database (KID). Presented at the International Conference of Pharmacoepidemiology, August 24-26 2015, Boston, MA.

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Academy Health Annual Research Meeting, June 14-15, 2015, Minneapolis, MN.

Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. Comparison of trends in bronchiolitis and respiratory syncytial virus infant hospitalizations rates in 3 US nationally representative databases. Presented at the Pediatric Academic Societies Annual Meeting, April 25-28 2015, San Diego, CA.

Liu B, Karath SM, Sekeres MA, Fryzek JP, Mutetwa BT, Sreekantaiah C, Mason C, Kolitz, Taioli E. Insights into the spatial clustering and disease etiology of myelodysplastic syndromes. Presented at the New York City Epidemiology Forum, February 27, 2015, New York City, NY.

Kerath SM, Sekeres MA, Fryzek JP, Mutetwa BT, Sreekantaiah C, Mason CR, Kolitz J, Taioli E. Clinical characteristics and outcomes in a large sample of MDS patients. Presented at the American Public Health Association (APHA) Annual Meeting and Exposition, November 15-19 2014, New Orleans, LA.

Meddings J, Saint S, Krein S, Gaies E, Reichert H, Hickner A, McNamara S, Mody L. Systematic review of interventions to reduce catheter-associated urinary tract infection in the long-term care setting. Presented at ID Week, October 10, 2014, Philadelphia, PA.

Reichert H, McMahon LF, Meddings J. Did hospital-acquired pressure ulcer rates decrease after implementation of non-payment as a comorbidity with the 2008 Hospital-Acquired Conditions Initiative? Presented at the Academy Health Annual Research Meeting, June 8-10, 2014, San Diego, CA.

Reichert H, McMahon LF, Meddings J. Risk-adjusting hospital-acquired pressure ulcer rates from administrative data: how do hospitals perform by the risk-adjusted AHRQ Patient Safety Indicator 3 compared to a proposed measure using risk-standardization applied by the Centers for Medicare and Medicaid Services for other outcomes? Presented at the Academy Health Annual Research Meeting, June 8-10, 2014, San Diego, CA.

Reichert H, Welch K. Conceptualizing Statistics: A Heuristic Approach. Presented at the University of Michigan’s Division of General Medicine Spring Retreat, May 1, 2014, Ann Arbor, MI.

Budelmann C, Reichert H, Meddings J. Are you ex-Foley-ating? A hospital-wide intervention to decrease urinary catheter use, including nurse-directed positive-reinforcement strategies. Presented at the Society of General Internal Medicine Annual Meeting, April 23-26, 2014, San Diego, CA.

Reichert H, McMahon LF, Meddings J. Hospital-acquired catheter-associated urinary tract infections: reported by mandate to the National Healthcare Safety Network, but rarely listed as diagnoses in claims data. Presented at the Society of General Internal Medicine Annual Meeting, April 23-26, 2014, San Diego, CA.

Cohen SS, Skovbo S, Vestergaard H, Kristensen T, Moller M, Bindslev-Jensen C, Fryzek JP, Broesby-Olsen S.  2014. Epidemiology of systemic mastocytosis in Denmark. Br J Haematol 166(4):521-528.

Hedgeman E, Lipworth L, Lowe K, Saran R, Do T, Fryzek J. International burden of chronic kidney disease: review of the literature and online data systems. National Kidney Foundation Spring Clinical Meeting, April 22-26, 2014, Las Vegas, NV.

Reichert H, Welch K. Conceptualizing Statistics: A Heuristic Approach. Presented at the 2014 American Statistical Association (ASA) Conference on Statistical Practice, February 20-22, 2014, Tampa, FL.

Reichert H, Meddings J. What’s so Standard About Risk Standardization? Presented at the 2014 American Statistical Association (ASA) Conference on Statistical Practice, February 20-22, 2014, Tampa, FL.

Reichert, H. Qualtrics (and other survey tools): Beyond Opinion Surveys. Presented at the University of Michigan Institute for Healthcare Policty and Innovation (IHPI) Methods Seminar, February 1, 2014, Ann Arbor, MI.

Mehta J, Wang H, Fryzek JP, Iqbal SU, Mesa R. 2014. Health resource utilization and cost associated with myeloproliferative neoplasms (MPN) in a large United States health plan. Leuk Lymphoma 55(10), DOI: 10.3109/10428194.2013.879127.

Moulard O, Mehta J, Fryzek J, Olivares R, Iqbal U, Mesa RA. 2013. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol 92(4):289-297, https://doi.org/10.1111/ejh.12256.

Johannesdottir S, Christiansen C, Johansen M, Olsen M, Xiao X, Parker J, Molfino N, Lash T, Fryzek J. 2013. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: A population-based Danish cohort study. J Med Econ 16(7),DOI: 10.3111/13696998.2013.800525.

Metha J, Le-Ruet O, Fryzek J, Iqbal U, Olivares R, Mesa R. Epidemiology of primary myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Presented at the European Cancer Congress (ESMO), September 27-October 1, 2013, Amsterdam, Netherlands.

Svendsen ML, Gammelager H, Sværke C, Yong M, Chia VM, Christiansen CF, Fryzek JP. 2013. Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: A nationwide population-based cohort study in Denmark. Clin Epidemiol 5:97-103, DOI: 10.2147/CLEP.S42325.

Meddings J, Reichert H, Grazier KL, Rogers MAM, Hofer T, McMahon LF. Effect of Payment Changes for Pressure Ulcers from the Hospital-Acquired Conditions Initiative: A Statewide Analysis. Presented at the 2013 AcademyHealth Annual Research Meeting, June 23-25, 2013, Baltimore, MD.

Nguyen-Nielsen M, Skovbo S, Svaneby D, Pedersen L, Fryzek J. 2013. The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995-2010. Eur J Med Genet 56(5):236-242. DOI.org/10.1016/j.ejmg.2013.01.012.

Meddings J, Reichert H, Rogers MAM, Hofer T, McMahon LF. Risk-adjusting Hospital-acquired Pressure Ulcer Rates from Claims Data: Teaching Hospitals Beware. Presented at the 2013 AcademyHealth Annual Research Meeting, June 23-25, 2013, Baltimore, MD.

Bylsma LC. Parental Trust in Health Information Sources and Influenza Vaccination in Children. Presented at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference, June 9-13, 2013, Pasadena, CA.

Reichert, H. Risk Standardization. Presented at the Institute for Healthcare Policy and Innovation (IHPI) Methods Seminar, June 1, 2013, Ann Arbor, MI.

Meddings J, Reichert H, Rogers MAM, Hofer T, McMahon LF. Risk-adjusting Hospital-acquired Pressure Ulcer Rates from Claims Data: Teaching Hospitals Beware. Presented at the 2013 Society of General Internal Medicine Annual Meeting, April 24-27, 2013, Denver, CO.

Meddings J, Reichert H, Grazier KL, Rogers MAM, Hofer T, McMahon LF. Effect of Payment Changes for Pressure Ulcers from the Hospital-Acquired Conditions Initiative: A Statewide Analysis. Presented at the 2013 Society of General Internal Medicine Annual Meeting, April 24-27, 2013, Denver, CO.

Mitchell ME, Lowe K, Fryzek J. 2012. A multisource approach to improving epidemiologic estimates: Application to global B-cell malignancies. ISRN Oncol 2012:129713.

Li J, Dalvi T, Pawaskar M, Tsai K, Caspard H, Fryzek J. Recent trends in the characteristics of patients with distant stage breast cancer in the United States Surveillance, Epidemiology and End Stage Disease program. Presented at the 2012 CTRC−AACR San Antonio Breast Cancer Symposium, December 4-8, 2012, San Antonio, TX.

Nielsen Nguyen M, Pedersen, Olesen Braae A, Wang L, Hou J, Mackey H, McCusker M, Basset-Seguin N, Fryzek J. The incidence of metastatic basal cell carcinoma in Denmark, 1997-2010. Presented at the 6th World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers in conjunction with the 8th EADO Congress, November 14-17 2012, Barcelona, Spain.

Nielsen Nguyen M, Skovbo S, Svaneby D, Pedersen L, Fryzek JP. The prevalence of X-linked hypohidrotic ectodermal dysplasia in Denmark, 1995-2010. Presented at the American Society of Human Genetics Annual Meeting, November 6-10, 2012, San Francisco, CA.

Meddings J, Reichert H, Saint S, McMahon LF. Why are hospital rates of catheter-associated UTIs so low in claims data? Presented at the 2012 Society for Healthcare Epidemiology of America / ID Week, October 17-21, 2012, San Diego, CA.

Deuson R, Danese M, Mathias SD, Schoonen M, Fryzek J. 2012. The burden of immune thrombocytopenia in adults: Evaluation of the thrombopoietin receptor agonist romiplostim. J Med Econ 15(5):956-976.

Yoon D, Fryzek JP, Doemland ML, Kim SM. Prescription pattern dispensed from pharmacies in South Korea, using national health insurance data. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Skovbo S, Nguyen-Nielsen, Pedersen, Sørensen HT, Fryzek J. The Prevalence of X-linked Hypohidrotic Ectodermal Dysplasia in Denmark from 1995-2010. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu Xiao, Lash TL, Sørensen HT, Fryzek JP. Healthcare resource utilization associated with hospitalization for acute exacerbation of chronic obstructive pulmonary disease and subsequent post-hospitalization recurrence and death a: a Danish cohort study. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Kuehn C, Watson H, Ong K, Mohamed M, Ochoa JA, Fryzek J. Descriptive Epidemiology of Medical Device Use among Patients with Breast, Lung or Prostate Cancer in the National Inpatient Sample. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Meddings J, Reichert H, Rogers MAM, Hofer TP, McMahon L. Adjusting for patients’ clinical risk of urinary tract infections: a necessary step in pay-for-performance when comparing by hospital-acquired complication rates. Presented at the 2012 AcademyHealth Annual Meeting, June 24-26, 2012, Orlando, FL.

Meddings J, Reichert H, McMahon L. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Presented at the 2012 AcademyHealth Annual Meeting, June 24-26, 2012, Orlando, FL.

Meddings J, Reichert H, Rogers MAM, Iwashyna TJ, McMahon L. Hospitals reporting better adherence to perioperative blood clot prophylaxis do not report lower rates of hospital-acquired post-operative blood clots. Presented at the 2012 AcademyHealth Annual Meeting, June 24-26, 2012, Orlando, FL.

Fordyce T, Mowat F, Fryzek J, Lau E. Incidence of metastatic hormone receptor positive (HR+) breast cancer in the United Kingdom: Data Needed. Presented at the 17th Annual International Society for Pharacoeconomics and Outcomes Research, June 2-6, 2012, Washington, DC.

Meddings J, Reichert H, Rogers MAM, Iwashyna TJ, McMahon L. Hospitals reporting better adherence to perioperative blood clot prophylaxis do not report lower rates of hospital-acquired post-operative blood clots. Presented at the 2012 Society of General Internal Medicine Annual Meeting, May 9-12, 2012, Orlando, FL.

Meddings J, Reichert H, McMahon L. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Presented at the 2012 Society of General Internal Medicine Annual Meeting, May 9-12, 2012, Orlando, FL.

Meddings J, Reichert H, Rogers MAM, Hofer TP, McMahon L. Adjusting for patients’ clinical risk of urinary tract infections: a necessary step in pay-for-performance when comparing by hospital-acquired complication rates. Presented at the 2012 Society of General Internal Medicine Annual Meeting, May 9-12, 2012, Orlando, FL.

Groothuis JR, Fryzek JP, Makari D, Steffey D, Martone WJ. 2011. Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998-2008. Clin Epidemiol 3:245-250.

Yong M, Christiansen CF, Gammelager H, Sværke C, Chia V, Atchison C, Fryzek J. Healthcare resource utilization among breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1997 – 2009). Presented at the 34th Annual San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX.

Yong M, Jensen AÖ, Jacobsen JB, Nørgaard M, Fryzek JP, Sørensen HT. 2011. Survival in breast cancer patients with bone metastases and skeletal-related events: A population-based cohort study in Denmark (1999-2007). Breast Cancer Res Treat 129(2):495-503.

Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, Sørensen HT. 2011. Incidence of acute kidney injury in cancer patients: A Danish population-based cohort study. Eur J Intern Med 22(4):399-406.

Osborn CY, Patel KA, Liu J, Trott HW, Buchowski MS, Hargreaves MK, Blot WJ, Cohen SS, Schlundt DG. 2011. Diabetes and co-morbid depression among racially diverse, low-income adults. Ann Behav Med 41(3):300-309.

Yong M, Riis AH, Fryzek JP, Møller BK, Johnsen SP. 2011. Predictors and patterns of red blood cell transfusion use among newly diagnosed cancer patients with chemotherapy-associated anemia in Western Denmark (1998-2003). Clin Epidemiol 3:91-99.

Mitchell J, Mehta J, Lau E, Fryzek J. National-level descriptive epidemiology of pediatric acute lymphoblastic leukemia. Presented at the 24th Annual Meeting of the American Society of Pediatric Hematology/Oncology, April 13-16, 2011, Baltimore, MD.

Beebe-Dimmer J, Morgenstern H, Cetin K, Yee C, Bartoces M, Shahinian V, Fryzek J, Acquavella J, Schwartz KL. 2011. Androgen deprivation therapy and cataract incidence among elderly prostate cancer patients in the United States. Ann Epidemiol 21(3):156-163.

Fryzek JP, Martone WJ, Groothuis JR. 2011. Trends in chronologic age and infant respiratory syncytial virus hospitalization: An 8-year cohort study. Adv Ther 28(3):195-201.

Jensen AØ, Jacobsen JB, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. 2011. Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark. BMC Cancer 11:29.

Jensen AO, Nørgaard M, Engebjerg MC, Farkas DK, Fryzek JP, Zhao S, Sørensen HT. 2011. Predictors for splenectomy among patients with primary chronic immune thrombocytopenia: A population-based cohort study from Denmark. Ann Hematol 90(2):207-212.

De Roos AJ, Deeg HJ, Onstad L, Kopecky KJ, Bowles EJ, Yong M, Fryzek J, Davis S. 2010. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006. Am J Hematol 85(10):765-770.

Cronin-Fenton DP, Søndergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sørensen HT. 2010. Hospitalisation for venous thromboembolism in cancer patients and the general population: A population-based cohort study in Denmark, 1997-2006. Br J Cancer 103(7):947-953.

Fryzek JP, Makari D, Martone WJ, Groothuis JR. Trends in Inpatient RSV Hospitalization in Young Children: An 8-Year Cohort Study using the US National Hospital Discharge Survey. Presented at the 3rd Congress of the European Academy of Paediatric Societies, October 23-26, 2010, Copenhagen, Denmark.

Groothuis JR, Fryzek JP, Makari D, Martone WJ. Respiratory Syncytial Virus Hospitalization (RSVH) in infants with Chronic Lung Disease: An 8 year Retrospective National Hospital Survey. Presented at the 3rd Congress of the European Academy of Paediatric Societies, October 23-26, 2010, Copenhagen, Denmark.

Nørgaard M, Jensen AØ, Jacobsen JB, Cetin K, Fryzek JP, Sørensen HT. 2010. Skeletal related events, bone metastasis and survival of prostate cancer: A population based cohort study in Denmark (1999 to 2007). J Urol 184(1):162-167.

Thomsen RW, Schoonen WM, Farkas DK, Riis A, Fryzek JP, Sørensen HT. 2010. Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: A 10-year nationwide cohort study. J Thromb Haemost 8(6):1413-1416.

Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, Fryzek J, Kaye JA. 2010. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol 149(6):855-864.

Cetin K, Beebe-Dimmer JL, Fryzek JP, Markus R, Carducci MA. 2010. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: Analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology 75(6):1396-1404.

Osborn CY, Trott HW, Buchowski MS, Patel KA, Kirby LD, Hargreaves MK, Blot WJ, Cohen SS, Schlundt DG. 2010. Racial disparities in the treatment of depression in low-income persons with diabetes. Diabetes Care 33(5):1050-1054.

Beebe-Dimmer J, Schwartz KA, Cetin K, Morgenstern H, Yee C, Bartoces M, Shahinian V, Fryzek J, Acquavella J. Incidence of cataract among elderly prostate cancer patients receiving androgen deprivation therapy in the United States using the Surveillance, Epidemiology, and End Results-Medicare database. Presented at the American Society of Clinical Oncology (ASCO) Annual Conference, June 9-11, 2010, Chicago, IL.

Yong M, Thomsen RW, Schoonen WM, Farkas DK, Riis A, Fryzek JP, Sørensen HT. 2010. Mortality risk in splenectomised patients: A Danish population-based cohort study. Eur J Intern Med 21(1):12-16.

Groothuis JR, Fryzek JP, Makari D, Martone WJ. Respiratory Syncytial Virus Hospitalization (RSVH) in infants with Chronic Lung Disease: An 8 year Retrospective National Hospital Survey. Presented at the 2010 Pediatric Academic Societies’ Annual Meeting, May 1-4, 2010, Vancouver, BC, Canada.

Du Y, Fryzek J, Sekeres MA, Taioli E. 2010. Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res 34(1):1-5.

Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K. 2009. The epidemiology of malignant giant cell tumors of bone: An analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004). Rare Tumors 1(2):e52.

Cohen SS, Signorello LB, Blot WJ. 2009. Adult weight gain and diabetes among African American and white adults in southeastern US communities. Prev Med 49(6):476-781.

Thomsen RW, Schoonen WM, Farkas DK, Riis A, Jacobsen J, Fryzek JP, Sørensen HT. 2009. Risk for hospital contact with infection in patients with splenectomy: A population-based cohort study. Ann Intern Med 151(8):546-555.

Jensen AØ, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. 2009. Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of Patients. Clin Epidemiol 1:101-108.

Evans M, Fored CM, Bellocco R, Fitzmaurice G, Fryzek JP, McLaughlin JK, Nyrén O, Elinder CG. 2009. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant 24(6):1908-1918.

Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, Fryzek J, Kaye JA. 2009. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 145(2):235-244.

Thomsen RW, Thomsen HF, Nørgaard M, Cetin K, McLaughlin JK, Tarone RE, Fryzek JP, Sørensen HT. 2008. Risk of cholecystitis in patients with cancer: A population-based cohort study in Denmark. Cancer 113(12):3410-3419.

Sekeres MA, Schoonen WM, Kantarjian H, List A, Fryzek J, Paquette R, Maciejewski JP. 2008. Characteristics of US patients with myelodysplastic syndromes: Results of six cross-sectional physician surveys. J Natl Cancer Inst 100(21):1542-1551.

Olsen JH, Friis S, Poulsen AH, Fryzek J, Harving H, Tjønneland A, Sørensen HT, Blot W. 2008. Use of NSAIDs, smoking and lung cancer risk. Br J Cancer 98(1):232-237.

Blot WJ, Signorello LB, Cohen SS, Ibrahim MA. 2007. Single leg separation prevalence among explanted Björk-Shiley prosthetic heart valves. J Heart Valve Dis 16(6):657-661.

Signorello LB, Schlundt DG, Cohen SS, Steinwandel MD, Buchowski MS, McLaughlin JK, Hargreaves MK, Blot WJ. 2007. Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status. Am J Public Health 97(12):2260-2267.

Fryzek JP, Holmich L, McLaughlin JK, Lipworth L, Tarone RE, Henriksen T, Kjøller K, Friis S. 2007. A nationwide study of connective tissue disease and other rheumatic conditions among Danish women with long-term cosmetic breast implantation. Ann Epidemiol 17(5):374-379.

Fryzek JP, Garabrant DH, Schenk M, Kinnard M, Greenson JK, Sarkar FH. The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations. Int J Gastrointest Cancer 37(4):139-145.

Fryzek JP, Poulsen AH, Lipworth L, Pedersen L, Nørgaard M, McLaughlin JK, Friis S. 2006. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 97(3):231-236.

Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM. 2005. The natural history of chronic renal failure: Results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 46(5):863-870.

Ejerblad E, Fored CM, Lindblad P, Fryzek J, Dickman PW, Elinder CG, McLaughlin JK, Nyrén O. 2004. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 15(8):2178-2185.

Henriksen TF, Hölmich LR, Friis S, McLaughlin JK, Fryzek JP, Pernille Høyer A, Kjøller K, Olsen JH. 2003. The Danish Registry for Plastic Surgery of the Breast: Establishment of a nationwide registry for prospective follow-up, quality assessment, and investigation of breast surgery. Plast Reconstr Surg 111(7):2182-2189; discussion 2190-2191.

Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder CG, Blot WJ, McLaughlin JK, Zack MM, Nyrén O. 2001. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 345(25):1801-1808.

Signorello LB, Ye W, Fryzek JP, Lipworth L, Fraumeni JF Jr, Blot WJ, McLaughlin JK, Nyrén O. 2001. Nationwide study of cancer risk among hip replacement patients in Sweden. J Natl Cancer Inst 93(18):1405-1410.

Lipworth L, Fryzek JP, Fored CM, Blot WJ, McLaughlin JK. 2001. Comparison of surrogate with self-respondents regarding medical history and prior medication use. Int J Epidemiol 30(2):303-308.

Blot WJ, Omar RZ, Kallewaard M, Morton LS, Fryzek JP, Ibrahim MA, Acheson D, Taylor KM, van der Graaf Y. 2001. Risks of fracture of Björk-Shiley 60 degree convexo-concave prosthetic heart valves: Long-term cohort follow up in the UK, Netherlands and USA. J Heart Valve Dis 10(2):202-209.

Fryzek JP, Signorello LB, Hakelius L, Lipworth L, McLaughlin JK, Blot WJ, Nyren O. 2001. Local complications and subsequent symptom reporting among women with cosmetic breast implants. Plast Reconstr Surg 107(1):214-221.

Fryzek JP, Signorello LB, Hakelius L, Feltelius N, Ringberg A, Blot WJ, McLaughlin JK, Nyren O. 2001. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg 107(1):206-213.

Fryzek JP, Mellemkjaer L, McLaughlin JK, Blot WJ, Olsen JH. 1999. Cancer risk among patients with finger and hand joint and temporo-mandibular joint prostheses in Denmark. Int J Cancer 81(5):723-725.